Department of Internal Medicine, Sultan Qaboos University, Muscat, Oman.
Department of Internal Medicine, Al-Nahdha Hospital, Muscat, Oman.
Sultan Qaboos Univ Med J. 2022 Nov;22(4):525-531. doi: 10.18295/squmj.6.2021.086. Epub 2022 Nov 7.
This study aimed to identify the main barriers that prevent patients with diabetes mellitus from accepting insulin therapy.
This cross-sectional study was conducted from May to December 2019. Convenience sampling was used to recruit participants from three diabetes clinics in Muscat, Oman. Eligible participants were interviewed in person based on a pre-prepared questionnaire. The questionnaire, which was administered in Arabic, includes demographic data and 19 specific items on barriers to insulin therapy.
A total of 201 participants (response rate: 93%) were enrolled in the study. The most common barriers were as follows: concern of frequent blood glucose checking (36.3%), long-term injections (33.8%), side-effects of insulin (29.9%) and weight gain (29.4%). Needle phobia was considered a barrier by only 9% of the participants. Overall, 125 (62.2%) participants were willing to initiate insulin therapy despite the presence of these barriers and only 20 (10%) of them were influenced by these barriers to such a degree that they rejected the insulin therapy.
The majority of participants had no identifiable reasons to stop them from accepting insulin therapy. Effective strategies should be developed to address each of the main barriers to improve acceptance and adherence to insulin therapy.
本研究旨在确定导致糖尿病患者拒绝胰岛素治疗的主要障碍。
本横断面研究于 2019 年 5 月至 12 月在阿曼马斯喀特的三家糖尿病诊所进行。采用便利抽样法招募参与者。根据预先准备好的问卷对符合条件的参与者进行面对面访谈。问卷以阿拉伯语进行，包括人口统计学数据和 19 个关于胰岛素治疗障碍的具体项目。
共有 201 名参与者（应答率：93%）纳入研究。最常见的障碍如下：担心频繁监测血糖（36.3%）、长期注射（33.8%）、胰岛素的副作用（29.9%）和体重增加（29.4%）。仅有 9%的参与者认为害怕针头是一个障碍。总体而言，尽管存在这些障碍，仍有 125 名（62.2%）参与者愿意开始胰岛素治疗，而仅有 20 名（10%）参与者受到这些障碍的影响，以至于他们拒绝胰岛素治疗。
大多数参与者没有明显的理由阻止他们接受胰岛素治疗。应制定有效的策略来解决主要障碍中的每一个，以提高对胰岛素治疗的接受度和依从性。
